by Dr. David Brownstein

Colon cancer is the second leading cancer killer in the U.S.  In fact, in 2009, 136,717 people were diagnosed with colon cancer and 51,849 died from it.(1)  Colonoscopies are one of the most common medical procedures done today.  A colonoscopy is performed in order to identify a growth or a polyp at an early stage so that it can be removed it before it becomes cancerous.  Colonoscopies are one of the few preventive procedures in conventional medicine that actually improve mortality.

It is well known that patients who have colonic polyps removed at an increased risk of recurrence.  A recent study looked at the efficacy of using antioxidants to prevent recurrent colonic polyps in patients who have undergone colonoscopic removal of polyps.(2)

The scientists conducted a randomized, double-blind placebo-controlled trial which began in 1988.  411 subjects were randomized to receive either a placebo or an active compound—taken daily–containing selenium (200ug), zinc (30mg), vitamin A (2mg), vitamin C (180mg), and vitamin E (30mg).

The authors found that the 15-year cumulative incidence of recurrent polyps in the antioxidant group was 39% reduced as compared to the placebo group.

Comments:  This is an important study as colon cancer affects too many people.   Simply taking an antioxidant supplement significantly reduced the recurrence of pre-cancerous lesions in the colon. Antioxidant therapy is inexpensive and has little side effects.  It makes sense to ensure that you eat food high in antioxidants—fruits and vegetables.  Avoid food that depletes the body of antioxidants such as refined carbohydrates—bread, pasta, and cereal made from refined sources.

The results of this study are not surprising to me.  I have seen the positive results patients experience when they correct nutrient imbalances.  I suggest supplementing with a good multivitamin that has natural sources of nutrients.

Read the full article here: http://blog.drbrownstein.com/colon-cancer-reduced-with-antioxidants/

Sources

(1)    CDC.  http://www.cdc.gov/cancer/colorectal/

(2)    J. of Gastroent.  2013;48(6):698-705

We Lost the War on Cancer – Review of Alternative Cancer Therapies

eBook
Retail : $9⁹⁹
Now : $5⁹⁹

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.

Purchase the DVD – Free Shipping Available! Click image to view the trailer.